综合康复治疗联合叶酸、甲钴胺对脑梗死患者血同型半胱氨酸水平的影响

被引:12
作者
向云 [1 ]
尉洋 [2 ]
机构
[1] 广东医学院附属南山医院(广东省深圳市第六人民医院)
[2] 广东省深圳市南山区蛇口人民医院
关键词
脑梗死; 综合康复治疗; 同型半胱氨酸; 叶酸; 甲钴胺;
D O I
暂无
中图分类号
R743.33 [脑栓塞];
学科分类号
1002 ;
摘要
目的探讨综合康复治疗联合叶酸及甲钴胺注射液对脑梗死患者血同型半胱氨酸(Hcy)和功能障碍的影响。方法将88例伴高同型半胱氨酸血症的脑梗死患者随机分为对照组和康复治疗组,对照组给予常规口服阿司匹林片、叶酸片,肌肉注射甲钴胺注射液,康复治疗组在应用药物基础上加行脑梗死后综合康复治疗项目,包括针刺、运动疗法、作业疗法、理疗、认知功能训练等。入院24h内和治疗2周后测定患者血Hcy水平及改良Barthel指数(MBI)并行相关分析。结果两组血Hcy水平均较治疗前明显下降,MBI评分均较治疗前升高,但康复治疗组较对照组改善明显(P<0.05)。血清Hcy水平和MBI评分呈负相关性(P<0.05)。结论综合康复治疗联合叶酸、甲钴胺注射液治疗可有效降低脑梗死患者血Hcy水平,提示综合康复治疗不仅能够促进患者功能障碍的恢复,同时可以减轻高同型半胱氨酸血症对脑血管的毒性作用,有助于脑梗死患者的恢复和二级预防。
引用
收藏
页码:653 / 655
页数:3
相关论文
共 7 条
[2]  
Advances in Stroke: Recovery and Rehabilitation[J] . Michael Brainin,Richard D. Zorowitz.Stroke . 2013 (2)
[3]  
Lipid peroxidation dysregulation in ischemic stroke: Plasma 4-HNE as a potential biomarker?[J] . Wan-Chi Lee,Hau-Yang Wong,Yun-Yong Chai,Chan-Wei Shi,Naoya Amino,Shizuki Kikuchi,Shin-Hai Huang.Biochemical and Biophysical Research Communications . 2012 (4)
[4]   Transcobalamin 2 variant associated with poststroke homocysteine modifies recurrent stroke risk [J].
Hsu, F. -C. ;
Sides, E. G. ;
Mychaleckyj, J. C. ;
Worrall, B. B. ;
Elias, G. A. ;
Liu, Y. ;
Chen, W. -M. ;
Coull, B. M. ;
Toole, J. F. ;
Rich, S. S. ;
Furie, K. L. ;
Sale, M. M. .
NEUROLOGY, 2011, 77 (16) :1543-1550
[5]   Association Between VEGF Polymorphisms and Homocysteine Levels in Patients With Ischemic Stroke and Silent Brain Infarction [J].
Kim, Ok Joon ;
Hong, Seung Ho ;
Oh, Seung Hun ;
Kim, Tae Gon ;
Min, Kyung Tae ;
Oh, Doyeun ;
Kim, Nam Keun .
STROKE, 2011, 42 (09) :2393-U73
[6]   Association between plasma homocysteine levels and obstructive sleep apnoea in patients with ischaemic stroke [J].
Chen, Maogang ;
Wu, Bona ;
Ye, Xinchun ;
Zhou, Zhiming ;
Yue, Xuanye ;
Wang, Qizhang ;
Wang, Wanxiang ;
Jiang, Yongjun ;
Lian, Xuegan ;
Chen, Zhaoyao ;
Xu, Gelin ;
Liu, Xinfeng .
JOURNAL OF CLINICAL NEUROSCIENCE, 2011, 18 (11) :1454-1457
[7]  
B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial[J] . Lancet Neurology . 2010 (9)